Research
Metabolic adaptation
Semaglutide treatment resulted in significant reductions in body mass index (BMI), waist circumference, and HbA1c.
Practitioners can consider semaglutide as an effective treatment for reducing BMI and improving glycemic control in obese T2DM patients.
StrongSupportsmedium confidence
Semaglutide treatment resulted in significant reductions in body mass index (BMI), waist circumference, and HbA1c.
Why this rating
Based on the randomized trial design.
Source
Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study
László Imre Tóth et al. · International Journal of Molecular Sciences · 2025
rct · n=34Cited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →